sesamin has been researched along with Colitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, X; Cai, P; Cao, L; Gou, X; Huang, M; Jin, J; Xu, C; Zhao, Z | 1 |
| An, Q; Chen, S; Fu, BD; Li, JH; Shen, HQ; Yi, PF; Yu, JL; Zhang, CL; Zhou, XF | 1 |
2 other study(ies) available for sesamin and Colitis
| Article | Year |
|---|---|
Sesamin Enhances Nrf2-Mediated Protective Defense against Oxidative Stress and Inflammation in Colitis via AKT and ERK Activation.
Topics: Animals; Antioxidants; Caco-2 Cells; Colitis; Dioxoles; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; HEK293 Cells; Humans; Lignans; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; NF-E2-Related Factor 2; Oxidative Stress; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Transcriptional Activation | 2019 |
Sesamin protects against DSS-induced colitis in mice by inhibiting NF-κB and MAPK signaling pathways.
Topics: Animals; Anti-Inflammatory Agents; Colitis; Colon; Dextran Sulfate; Dioxoles; Lignans; Male; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; NF-kappa B; Protective Agents | 2021 |